Organization

Shanghai Zhengu Biological Technology Co., Ltd

2 abstracts

Abstract
Circulating tumor DNA–based detection of molecular residual disease as a biomarker for recurrence monitoring predict disease recurrence in patients with ovarian cancer.
Org: Ruijin Hospital, Shanghai Jiaotong University School, Shanghai, China, Shanghai Jiaotong University, School of Medicine, Shanghai Zhengu Biological Technology Co., Ltd, Pillar Biosciences Inc.,
Abstract
Copy number variation (CNV) calling of MET, MYC, and ERBB2 using PiVAT bioinformatic platform.
Org: Shanghai Zhengu Biological Technology Co., Ltd, Pillar Biosciences Inc.,